Matheus Victor, PhD
About Me
Matheus Victor, PhD, is an investigator of the Institute for Regenerative Medicine, the Ronald M. Loeb Center for Alzheimer’s Disease and the Friedman Brain Institute. Dr. Victor is an assistant professor in the Department of Neuroscience, and in the Department of Cell, Developmental and Regenerative Biology. He joins the faculty of the Icahn School of Medicine at Mount Sinai as an NIH FIRST Faculty Scholar and a Howard Hughes Medical Institute Hanna Gray Faculty Fellow.
Dr. Victor earned his Ph.D. in Neuroscience from Washington University in St. Louis where he pioneered a novel cellular reprogramming approach to study the contribution of aging to neurodegeneration. Dr. Victor conducted his postdoctoral training at MIT where he investigated how genetic susceptibility in microglia, the brain-resident immune cells, contributes to the pathobiology of Alzheimer’s disease.
At Mount Sinai, the Victor lab leverages 3D stem cell technologies, CRISPR-based tools, post-mortem human brain samples, and mouse models to elucidate the molecular, cellular, and systems-level consequences of glial perturbations associated with neurodegenerative diseases to the function of neural circuits.
Learn more about the Victor lab: www.victor-lab.com
Ongoing research interests include:
• Neuron-glia interactions in the pathophysiology of neurodegenerative diseases.
• Mechanisms of neuronal network assembly, remodeling, and degeneration with 3D cell culture models of the human brain.
• Molecular, cellular and circuit level mechanisms governing neuropsychiatric symptoms of Alzheimer’s disease.
Language
English
Position
ASSISTANT PROFESSOR | Neuroscience, ASSISTANT PROFESSOR | Stem Cell Biology And Regenerative Medicine
Research Topics
Alzheimer's Disease, Cellular Differentiation, Developmental Neurobiology, Induced pluripotent stem cells, Inflammation, Microglia, Neural Networks, Neuroscience
Multi-Disciplinary Training Areas
Development Regeneration and Stem Cells [DRS], Neuroscience [NEU]
Education
PhD, Washington University in St. Louis
Postdoctoral Training, Massachusetts Institute of Technology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Victor has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.